A detailed history of Canada Pension Plan Investment Board transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Canada Pension Plan Investment Board holds 134,762 shares of REGN stock, worth $111 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
134,762
Previous 125,290 7.56%
Holding current value
$111 Million
Previous $121 Million 17.45%
% of portfolio
0.15%
Previous 0.13%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$883.2 - $1071.19 $8.37 Million - $10.1 Million
9,472 Added 7.56%
134,762 $142 Million
Q1 2024

May 14, 2024

SELL
$902.69 - $993.35 $1.46 Million - $1.61 Million
-1,616 Reduced 1.27%
125,290 $121 Million
Q4 2023

Feb 14, 2024

SELL
$775.18 - $881.7 $10.5 Million - $12 Million
-13,600 Reduced 9.68%
126,906 $111 Million
Q3 2023

Nov 09, 2023

BUY
$692.45 - $844.37 $25.6 Million - $31.2 Million
37,000 Added 35.75%
140,506 $116 Million
Q2 2023

Aug 09, 2023

BUY
$700.03 - $830.35 $3.5 Million - $4.15 Million
5,000 Added 5.08%
103,506 $74.4 Million
Q1 2023

May 12, 2023

BUY
$680.49 - $826.97 $23.5 Million - $28.6 Million
34,550 Added 54.02%
98,506 $80.9 Million
Q4 2022

Feb 14, 2023

BUY
$705.89 - $766.39 $6.21 Million - $6.74 Million
8,800 Added 15.95%
63,956 $46.1 Million
Q3 2022

Nov 14, 2022

BUY
$573.97 - $724.32 $18.9 Million - $23.9 Million
32,993 Added 148.87%
55,156 $38 Million
Q2 2022

Aug 12, 2022

SELL
$548.35 - $738.84 $6.04 Million - $8.13 Million
-11,006 Reduced 33.18%
22,163 $13.1 Million
Q1 2022

May 13, 2022

SELL
$595.12 - $698.43 $57.9 Million - $67.9 Million
-97,265 Reduced 74.57%
33,169 $23.2 Million
Q4 2021

Feb 14, 2022

SELL
$543.48 - $670.97 $6.23 Million - $7.69 Million
-11,467 Reduced 8.08%
130,434 $82.4 Million
Q3 2021

Nov 15, 2021

SELL
$574.03 - $680.96 $5.08 Million - $6.03 Million
-8,857 Reduced 5.87%
141,901 $85.9 Million
Q2 2021

Aug 16, 2021

BUY
$472.8 - $558.54 $49.5 Million - $58.5 Million
104,718 Added 227.45%
150,758 $84.2 Million
Q1 2021

May 17, 2021

BUY
$446.73 - $548.2 $17.6 Million - $21.6 Million
39,348 Added 587.99%
46,040 $21.8 Million
Q4 2020

Feb 17, 2021

BUY
$478.3 - $607.98 $622,268 - $790,981
1,301 Added 24.13%
6,692 $3.23 Million
Q3 2020

Nov 12, 2020

SELL
$544.75 - $658.21 $6.73 Million - $8.13 Million
-12,353 Reduced 69.62%
5,391 $3.02 Million
Q2 2020

Aug 14, 2020

BUY
$493.32 - $643.92 $99,157 - $129,427
201 Added 1.15%
17,744 $11.1 Million
Q1 2020

May 13, 2020

SELL
$336.18 - $494.43 $4 Million - $5.88 Million
-11,896 Reduced 40.41%
17,543 $8.57 Million
Q4 2019

Feb 14, 2020

SELL
$274.13 - $376.51 $44.5 Million - $61.1 Million
-162,244 Reduced 84.64%
29,439 $11.1 Million
Q3 2019

Nov 12, 2019

SELL
$273.46 - $318.39 $9.81 Million - $11.4 Million
-35,857 Reduced 15.76%
191,683 $53.2 Million
Q2 2019

Aug 12, 2019

BUY
$299.6 - $414.82 $19.8 Million - $27.5 Million
66,191 Added 41.02%
227,540 $71.2 Million
Q1 2019

May 15, 2019

BUY
$372.08 - $439.57 $5.31 Million - $6.27 Million
14,275 Added 9.71%
161,349 $66.3 Million
Q4 2018

Feb 06, 2019

BUY
$335.82 - $403.04 $13.9 Million - $16.7 Million
41,449 Added 39.24%
147,074 $54.9 Million
Q3 2018

Nov 09, 2018

SELL
$351.14 - $408.51 $45.2 Million - $52.6 Million
-128,741 Reduced 54.93%
105,625 $42.7 Million
Q2 2018

Aug 07, 2018

BUY
$284.6 - $344.99 $30.9 Million - $37.5 Million
108,691 Added 86.49%
234,366 $80.9 Million
Q1 2018

May 14, 2018

BUY
$315.82 - $393.78 $8.81 Million - $11 Million
27,900 Added 28.53%
125,675 $43.3 Million
Q4 2017

Feb 14, 2018

BUY
$358.63 - $469.95 $22.1 Million - $28.9 Million
61,600 Added 170.28%
97,775 $36.8 Million
Q3 2017

Oct 30, 2017

BUY
$431.38 - $504.0 $6.1 Million - $7.13 Million
14,147 Added 64.22%
36,175 $16.2 Million
Q2 2017

Jan 31, 2018

SELL
N/A
-19,229 Reduced 46.61%
22,028 $10.8 Million
Q1 2017

Jan 31, 2018

BUY
N/A
41,257
41,257 $16 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $88.4B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Canada Pension Plan Investment Board Portfolio

Follow Canada Pension Plan Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Canada Pension Plan Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on Canada Pension Plan Investment Board with notifications on news.